VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $88,657,000 | -71.4% | 872,178 | -49.9% | 1.70% | -72.7% |
| Q3 2015 | $310,419,000 | +65.0% | 1,740,214 | +105.5% | 6.22% | +123.3% |
| Q2 2015 | $188,145,000 | +3.1% | 846,927 | -7.8% | 2.78% | +9.3% |
| Q1 2015 | $182,517,000 | +97.2% | 918,924 | +25.2% | 2.55% | +69.2% |
| Q2 2014 | $92,543,000 | -59.3% | 733,772 | -57.5% | 1.50% | -68.9% |
| Q1 2014 | $227,466,000 | -26.7% | 1,725,450 | -34.7% | 4.85% | -31.8% |
| Q4 2013 | $310,278,000 | +34.7% | 2,642,912 | +19.7% | 7.11% | +18.2% |
| Q3 2013 | $230,369,000 | +31.6% | 2,208,083 | +8.6% | 6.01% | +17.6% |
| Q2 2013 | $175,023,000 | – | 2,033,263 | – | 5.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |